CMS launches its Medicare GLP-1 Bridge July 1, giving eligible Medicare Part D beneficiaries access to weight-loss GLP-1s at a $50 monthly copay through December 2027. For health systems and pharmacy ...

The Centers for Medicare and Medicaid Services’ Medicare GLP-1 Bridge program will decrease certain GLP-1 costs, which local ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...

Fact checked by Jennifer Klump Key Takeaways The Medicare GLP-1 Bridge program will cover weight loss drugs for a $50 monthly ...

What I saw in those archives, and what I have watched unfold in the United States over the past three decades, are not two separate stories. They are one story, told in two languages. I. The Blueprint ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 7:20 PM EDTCompany ParticipantsShane Gleason - Chief ...

The DoJ secured record-breaking False Claims Act recoveries of $6.8 billion in fiscal year 2025, with $76 million from the ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 4:40 PM EDTCompany ParticipantsJason Beach - VP and Group CFO ...

Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs under brand names Ozempic ...

Atrioventricular Interval Modulation (“AVIM”) Therapy Food and Drug Administration (“FDA”) Breakthrough Device Designations span the broader population of patients with uncontrolled hypertension ...

The IMpactMF trial’s interim analysis in the second half of 2026 is presented as a potential catalyst with implications for both product expansion and physician awareness. Expectations for back-half ...

Vertex stock skidded Tuesday on a mixed first-quarter report, but analysts remain more interested in the company's R&D plans.